URATE OXIDASE IN HYPERURICEMIC HEART TRANSPLANT RECIPIENTS TREATED WITH AZATHIOPRINE
- 1 May 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 63 (9) , 1370,1371-1
- https://doi.org/10.1097/00007890-199705150-00032
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- MYELOSUPPRESSION ASSOCIATED WITH AZATHIOPRINE-ALLOPURINOL INTERACTION AFTER HEART AND LUNG TRANSPLANTATIONTransplantation, 1996
- Cyclosporine-Induced Hyperuricemia and GoutNew England Journal of Medicine, 1989
- Pharmacokinetics of azathioprine and 6‐mercaptopurine after oral administration of azathioprineClinical Transplantation, 1987
- Renal Histopathologic Alterations in Patients Treated with Cyclosporine for UveitisNew England Journal of Medicine, 1986
- Cyclosporine-Associated Chronic NephropathyNew England Journal of Medicine, 1984
- HYPOURICAEMIC EFFECT OF POLYETHYLENEGLYCOL MODIFIED URATE OXIDASEThe Lancet, 1981
- TREATMENT OF MALIGNANT HÆMOPATHIES AND URATE OXIDASEThe Lancet, 1975
- Factors affecting urate excretion following diuretic administration in manThe American Journal of Medicine, 1969